- Home
- BFRG vs COCP Comparison
BFRG vs COCP Comparison
Compare BFRG & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRG
- COCP
- Stock Information
- Founded
- BFRG 2017
- COCP N/A
- Country
- BFRG United States
- COCP United States
- Employees
- BFRG N/A
- COCP N/A
- Industry
- BFRG Retail: Computer Software & Peripheral Equipment
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- BFRG Technology
- COCP Health Care
- Exchange
- BFRG Nasdaq
- COCP Nasdaq
- Market Cap
- BFRG 21.2M
- COCP 18.3M
- IPO Year
- BFRG 2023
- COCP N/A
- Fundamental
- Price
- BFRG $2.04
- COCP $2.27
- Analyst Decision
- BFRG
- COCP Strong Buy
- Analyst Count
- BFRG 0
- COCP 1
- Target Price
- BFRG N/A
- COCP $7.00
- AVG Volume (30 Days)
- BFRG 201.5K
- COCP 24.1K
- Earning Date
- BFRG 11-08-2024
- COCP 11-13-2024
- Dividend Yield
- BFRG N/A
- COCP N/A
- EPS Growth
- BFRG N/A
- COCP N/A
- EPS
- BFRG N/A
- COCP N/A
- Revenue
- BFRG N/A
- COCP N/A
- Revenue This Year
- BFRG N/A
- COCP N/A
- Revenue Next Year
- BFRG N/A
- COCP N/A
- P/E Ratio
- BFRG N/A
- COCP N/A
- Revenue Growth
- BFRG 550.00
- COCP N/A
- 52 Week Low
- BFRG $1.43
- COCP $1.33
- 52 Week High
- BFRG $8.35
- COCP $3.10
- Technical
- Relative Strength Index (RSI)
- BFRG 41.32
- COCP 65.05
- Support Level
- BFRG $2.11
- COCP $1.90
- Resistance Level
- BFRG $2.77
- COCP $1.99
- Average True Range (ATR)
- BFRG 0.29
- COCP 0.17
- MACD
- BFRG -0.03
- COCP 0.02
- Stochastic Oscillator
- BFRG 7.32
- COCP 84.62
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).